{"id":1865,"date":"2025-10-31T00:14:22","date_gmt":"2025-10-31T05:14:22","guid":{"rendered":"https:\/\/www.creative-diagnostics.com\/blog\/?p=1865"},"modified":"2025-10-31T00:14:24","modified_gmt":"2025-10-31T05:14:24","slug":"crispr-cas9-based-genome-editing-in-staphylococcus-aureus-advances-applications-and-future-prospects","status":"publish","type":"post","link":"https:\/\/www.creative-diagnostics.com\/blog\/index.php\/crispr-cas9-based-genome-editing-in-staphylococcus-aureus-advances-applications-and-future-prospects\/","title":{"rendered":"CRISPR-Cas9-Based Genome Editing in Staphylococcus aureus: Advances, Applications, and Future Prospects<\/strong>"},"content":{"rendered":"\n

Introduction<\/strong><\/strong><\/p>\n\n\n\n

Staphylococcus aureus (S. aureus) is a Gram-positive opportunistic pathogen that can cause a variety of diseases, from skin and soft tissue infections to severe necrotizing pneumonia, endocarditis, and toxic shock syndrome. The emergence of multidrug-resistant S. aureus (MRSA) has become a major threat to global healthcare. Novel therapeutic approaches are in great demand, including genetic manipulation and new antibacterial targets.<\/p>\n\n\n\n

\"\"<\/a><\/figure>\n\n\n\n

The sigB gene encodes the alternative sigma factor \u03c3^B, which is a stress response regulator, and it is also involved in the regulation of virulence expression, biofilm formation, and adaptive stress responses in adverse host environments. The sigB has been regarded as a potential drug target for S. aureus virulence attenuation and infection control.<\/p>\n\n\n\n

Traditional genetic manipulation methods, including allelic replacement, counter-selection, and TargeTron group II intron systems, have been used in S. aureus for gene functional studies. These approaches are laborious, time-consuming, and have low efficiency. The recently developed CRISPR-Cas9 technology has become a powerful genome-editing platform, enabling bacterial genetics to be conducted in a precise, flexible, and efficient manner.<\/p>\n\n\n\n

In this review, we will be going over the use of CRISPR-Cas9 on S. aureus, more specifically, studies involving the knockout of sigB. We will be discussing the methods, what biological functions were discovered and the implications of this work for antimicrobials.<\/p>\n\n\n\n

Mechanisms of CRISPR-Cas9 Genome Editing<\/strong><\/strong><\/p>\n\n\n\n

CRISPR-Cas9 system was derived from prokaryotes, which naturally has its own defense mechanism against bacteriophage. This system, involving the Cas9 endonuclease and the single-guide RNA (sgRNA), has been engineered to cause double-stranded breaks at defined loci that can be repaired by NHEJ or, when donor DNA is provided, by HR.<\/p>\n\n\n\n

In S. aureus, CRISPR-Cas9-mediated editing typically relies on HR for precise knockout or replacement of target genes. To enhance editing efficiency, plasmid-based systems such as pCasSA vectors have been constructed, incorporating both Cas9 and sgRNA expression cassettes.<\/p>\n\n\n\n

Traditional Approaches Versus CRISPR-Cas9<\/strong><\/strong><\/p>\n\n\n\n

Before CRISPR-Cas9, gene editing in S. aureus was constrained by low efficiency. Allelic exchange methods required multiple rounds of selection and counter-selection. TargeTron systems using group II introns allowed targeted disruption but were limited by insertional mutagenesis and temperature sensitivity.<\/p>\n\n\n\n

CRISPR-Cas9 surpasses these methods by offering:<\/p>\n\n\n\n